Dexcom is a company that designs, develops, and provides medical devices with a focus on the development and commercialization of continuous glucose monitoring (CGM) systems. Dexcom simplifies and improves diabetes management around the world by continuously measuring glucose level with its small implantable device. To empower people to take control of diabetes, Dexcom has been providing patients with the leading technology of CGM, helping them with diabetes lead healthier, fuller, and longer lives.
53 Reviews
Pay is relatively good for area. There are a lot of genuinely smart and good people at the company.
Extremely bloated leadership layer which prevents anything from getting done. Projects constantly stall so everyone can get perfectly aligned, and it never actually happens. Just a constant and soul-crushing waste of time and resources
Shares of DexCom Inc. shed 0.09% to $96.84 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...
DexCom (NASDAQ:DXCM) will be releasing earnings after the market closes on Thursday, October 27, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=301796)
US$ 164,000
Median Total Comp
25TH%
70TH%
90TH%